Proxy Results (Form 8-K)

On February 19, 2026, Tivic Health Systems, Inc. (the "Company") convened and then adjourned its special meeting of stockholders (the "Special Meeting") for stockholders to vote on the proposals described in the Company's definitive proxy statement filed with the Securities and Exchange Commission (the "SEC") on January 9, 2026 and mailed to stockholders on January 9, 2026, as supplemented by the Company's proxy supplement filed with the SEC on February 9, 2026 and mailed to stockholders on February 18, 2026 (together, the "Proxy Statement"). As of December 29, 2025, the record date for the Special Meeting, there were 2,525,778 shares of common stock issued and outstanding and entitled to vote at the Special Meeting. Stockholders holding less than one-third of the capital stock issued and outstanding and entitled to vote at the Special Meeting were present in person (by virtual attendance) or represented by proxy at the Special Meeting. Because a quorum was not present, pursuant to the Company's Amended and Restated Bylaws (the "Bylaws"), the chairperson of the Special Meeting adjourned the Special Meeting. The Special Meeting was scheduled to reconvene virtually at www.virtualshareholdermeeting.com/TIVC2026SM on March 12, 2026 at 1:00 p.m. Pacific Time (the "Adjourned Meeting").

On March 11, 2026, the Board of Directors of the Company adopted a resolution, pursuant to Section 2.16 of the Bylaws, to cancel the Adjourned Meeting. In connection therewith, the Company filed this current report on Form 8-K announcing the cancellation of the Adjourned Meeting and the Company's withdrawal from consideration by the Company's stockholders the proposals set forth in the Proxy Statement.